News
🇺🇸 AmericasLatest pharmaceutical news, drug approvals, and FDA regulatory updates
Latest News
FDA Approves First Interchangeable Humira Biosimilar: Key Details
The FDA has approved the first interchangeable biosimilar to Humira, a significant milestone for patients with autoimmune conditions seeking affordable treatment alternatives.
FDA Approves Gilead's Long-Acting HIV Treatment for Bi-Monthly Dosing
Gilead's long-acting HIV treatment has received FDA approval for bi-monthly dosing, providing patients with a more convenient and effective management option.
FDA Grants Priority Review to AstraZeneca's Wilson Disease Treatment
AstraZeneca's innovative treatment for Wilson Disease has received priority review from the FDA, potentially transforming care for patients with this copper metabolism disorder.
FDA Grants Accelerated Approval to Eli Lilly's Donanemab for Alzheimer's
Eli Lilly's Donanemab receives accelerated FDA approval for Alzheimer's, offering new hope for patients and families affected by this challenging disease.
FDA Approves Novartis' Novel Breast Cancer Drug in Landmark Decision
In a landmark decision, the FDA has approved Novartis' innovative breast cancer drug, marking a significant advancement in treatment options for patients.
FDA Approves Breakthrough KRAS Inhibitor Lumakras for Lung Cancer
The FDA has approved Lumakras, a groundbreaking KRAS inhibitor, providing a new targeted therapy option for patients battling lung cancer.
FDA Approves Talvey (talquetamab) for Relapsed Multiple Myeloma
The FDA has granted approval for Talvey (talquetamab), a groundbreaking treatment option for patients with relapsed multiple myeloma, enhancing therapeutic choices.